Doha, Qatar (ots/PRNewswire) - Dr. Sakena Yacoobi, Founder and Executive Director of the Afghan Institute of Learning (AIL) has been named the 2015 WISE Prize for Education Laureate. Popularly known as Afghanistan's mother of education, Dr.Yacoobi, 65, has spent two decades working persistently to rebuild her country's education landscape, devastated by war. The WISE Prize for Education was presented by Her Highness ...
Dublin And Marlow, England (ots/PRNewswire) - - Complements Allergan's leadership position in Medical Aesthetics and enhances offering to Plastic Surgeons - earFold(TM), for the correction of prominent ears and/or ear asymmetry in people aged 7 years and older,[1] was recently granted a CE mark for commercialisation in Europe - A minimally-invasive treatment ...
London (ots/PRNewswire) - ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as shareholders, today announced that the Phase IIb study LATTE 2 (NCT02120352) met its primary endpoint at 32 weeks. These results show that the investigational, long acting, injectable formulations ...
Cork, Ireland (ots/PRNewswire) - Injectable combinations once every 4 or 8 weeks show comparable efficacy versus daily oral combination therapy Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced that Phase IIb data studying a combination regimen of ...
Lausanne, Switzerland (ots/PRNewswire) - Recommended Dose reached and early signs of efficacy seen Debiopharm International SA (Debiopharm) - part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company - today announced significant milestones in the clinical development of the SMAC mimetic ...
Dublin And Burlington, Massachusetts (ots/PRNewswire) - Lead pipeline product, DX-2930, is a Phase 3-ready asset, offering potentially transformative prophylactic therapy for HAE - DX-2930 has potential to expand HAE-treated patients and achieve annual worldwide sales of up to $2 billion with exclusivity ...
Dallas (ots/PRNewswire) - 700,000 People Worldwide Rally behind Sign Against Stroke Task Force to Call AF Care and Stroke Prevention to be Prioritised on National Health Agendas On World Stroke Day, the Sign Against Stroke (SAS) in Atrial Fibrillation Task Force introduces the enhanced SignAgainstStroke.com ...
Munich (ots/PRNewswire) - - On World Stroke Day (29 October) a campaign by Daiichi Sankyo highlights stroke risks associated with cardiovascular diseases - People with atrial fibrillation have a five times higher stroke risk compared to the general population.[1] In Europe less than 50% of patients with ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - Data to support lifitegrast FDA resubmission in Q1 2016; plans on track for potential 2016 launch - The topline data showed OPUS-3, a phase 3 trial, met primary endpoint, demonstrating significant improvement in patient-reported symptoms from baseline to day 84 in ...
London (ots/PRNewswire) - ViiV Healthcare today awarded its first round of small grants to support men who have sex with men (MSM) and transgender community-led interventions to reduce stigma and discrimination based on sexual orientation, gender identity/expression and/or HIV status. 23 non-governmental and ...
Calgary, Alberta (ots/PRNewswire) - Apabetalone will be evaluated in a Phase 3 clinical trial in high-risk coronary artery disease and type 2 diabetes mellitus patients Resverlogix Corp. (the "Corporation") today announced the commencement of a Phase 3 clinical trial called 'BETonMACE' with lead drug apabetalone (RVX-208) in high-risk patients with coronary artery ...
Beerse, Belgium (ots/PRNewswire) - FOR UK AND EMEA MEDICAL MEDIA ONLY Janssen-Cilag International NV (Janssen) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending a change to the terms of the marketing ...
Teva Pharmaceutical Industries Ltd.
Prague (ots/PRNewswire) - Results from a new study at the 11th Congress of the European Society of Gynecology this week demonstrate that the majority of women in Europe prefer to have less frequent periods. The study recruited 2,883 women aged 18-45 years old from Austria, Belgium, France, Italy, Poland and ...
Physicians Interactive, Merck, Univadis
Reading, Massachusetts (ots/PRNewswire) - Authoritative Medical Content Platform Combined with Deep Digital Expertise Offers Greater Opportunities to Engage Healthcare Professionals and Improve Outcomes Physicians Interactive [http://www.physiciansinteractive.com ](R) (PI) announced today the launch of its recently acquired Univadis [http://www.univadis.com ] ...
Nuremberg, Germany (ots/PRNewswire) - - Findings on most common health complaints across 22 countries - Muscle pain, weight problems and migraines complete top 5 most common complaints - Women more prone to sleeping problems than men Half of people internationally say they have had a cough or cold in the last 12 months and over a quarter report suffering from ...
Geneva (ots/PRNewswire) - - UNESCO-Merck Africa Research Summit aims to define interventions to prepare for the road ahead in Africa's development as an international hub for research excellence and scientific innovation - Summit will put specific emphasis on how to translate knowledge into action to improve health - Summit to be conducted on a yearly basis to ensure significant sustainable impact; 2015 edition will ...
Hong Kong (ots/PRNewswire) - Demonstration of Clinical Effectiveness in One-year Target Lesion Failure OrbusNeich, a global company specializing in the provision of life-changing vascular solutions, has announced today the presentation of the one-year clinical outcomes from the one-thousand patient REMEDEE* Registry by Robbert de Winter, M.D., Ph.D., of the Academic ...
Munich (ots/PRNewswire) - World Thrombosis Day Interactive Infographic [http://af-vte.thisinfographic.com/wtd ] Daiichi Sankyo is proud to partner with World Thrombosis Day [http://www.worldthrombosisday.org ] to promote vital global awareness of thrombosis, its causes, risk factors, and signs and symptoms. ...
Copenhagen, Denmark (ots/PRNewswire) - Chr. Olesen Synthesis A/S, the privately held Danish manufacturer of active pharmaceutical ingredients (APIs), announced it has raised EUR10 million through the sale of Series A Preferred Stock to the American private equity firm, Signet Healthcare Partners. Chr. Olesen Synthesis, founded in the 1970's, was taken over in 2012 in a financial restructuring led by Chr. Olesen Group, a ...
JTI Japan Tobacco International AG
Geneva (ots/PRNewswire) - Delayed Publication of Government's Post-Implementation Review Raises Concern about its Integrity The Australian Government has yet to publish its Post-Implementation Review (PIR) into 'plain' packaging for tobacco products, six months after the consultation period ended. The delay has prompted concerns that the authors of the report could ...
United European Gastroenterology
Vienna (ots/PRNewswire) - It has been estimated that around one in 10 cases of bowel cancer can be linked to alcohol consumption[1] and the risk increases the more alcohol you drink[2]. One international group of researchers has estimated that the bowel cancer risk increases by 21% if you have two or three alcoholic drinks a day (1.5 to 6 units of alcohol) and by more than 50% if you have four or more drinks a day (6 ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - Shire plc is pleased to announce the winner and runner up of the Spotlight on Gaucher film contest on the occasion of International Gaucher Day (IGD). The film contest, which was supported by the European Gaucher Alliance (EGA), encouraged people whose lives have been touched by Gaucher disease to share a video to raise awareness of ...
Darmstadt, Germany (ots/PRNewswire) - - Agreement with BioMarin, a leading company in the treatment of genetic and rare diseases, also includes returning option to develop and commercialize Peg-Pal - Merck to receive upfront payment of EUR 340 million, plus up to EUR 185 million in additional milestones Merck, a ...
Nuremberg, Germany (ots/PRNewswire) - - 28 percent internationally are not confident in having enough money to live the "life they want" when they retire - While, 42 percent are confident that they will have enough money Internationally, close to three in ten (28 percent) lack confidence that they will be able to afford the life they want during retirement, ...
London (ots/PRNewswire) - ViiV Healthcare today announced 24-week data from the Phase IIIb/IV STRIIVING study, an open-label study evaluating the efficacy, safety and tolerability of switching from an antiretroviral therapy (ART) to the once-daily, fixed-dose dolutegravir-based regimen, Triumeq(R) (abacavir/dolutegravir/lamivudine) in virologically suppressed adults ...
Tokyo (ots/PRNewswire) - The National Institute for Health and Care Excellence (NICE), the medicines cost-effectiveness body for England and Wales, has recommended a new treatment to help prevent stroke and systemic embolism (SE) in patients suffering from the heart rhythm disorder atrial fibrillation (AF).[1] ...
Uithoorn, The Netherlands (ots/PRNewswire) - A leader in technology-based sales support tools, HOYA is proud to introduce its latest innovation: the HOYA Vision Simulator offers wearers the ability to experience their new lenses before they buy them, right in the store. Using wearers' actual prescription, the HOYA Vision Simulator provides a highly accurate, 3D vision experience, visualising the optical effects of the ...
Shire Pharmaceuticals Group Plc
Zug, Switzerland (ots/PRNewswire) - The first selective alpha-2A adrenergic receptor agonist licensed for the treatment of ADHD in the EU Shire today announced that the European Commission granted Marketing Authorisation for once-daily, non-stimulant INTUNIV(R) (guanfacine hydrochloride prolonged release ...
Chertsey, England (ots/PRNewswire) - Astellas Pharma Europe Ltd. today announced the European Commission has granted approval for a label extension for QUTENZA[TM] (capsaicin 8% patch) to include the treatment of adult diabetic patients with peripheral neuropathic pain, either alone or in combination with other ...
Lyon, France (ots/PRNewswire) - A relevant and comprehensive approach on the benefits of vaccines on healthcare systems sustainability and economic growth Sanofi Pasteur MSD is proud to announce the publication of a supplement dedicated to the economic value of vaccination in the Journal of Market Access and Health Policy. The series of 7 articles has been developed ...